José María Mora-Gutiérrez

Dr. José María Mora-Gutiérrez

Nephrology Department, Clínica Universidad de Navarra. Avenida Pio XII, 36. Pamplona 31008, Navarra, Spain
orcid

Research Focus & Metrics

Academic Career Length

10Years (2017-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
8 February 2020 in Journal of Clinical Medicine
Verified
Journal Article
Open access
PDF file
NGNuria Garcia-Fernandez
Nuria Garcia-Fernandez
CCConxita Jacobs Cachá
Conxita Jacobs Cachá
JMJosé María Mora-Gutiérrez
José María Mora-Gutiérrez
AVAnder Vergara
Ander Vergara
JOJosune Orbe
Josune Orbe
MSMaria Jose Soler
Maria Jose Soler
Around the world diabetic kidney disease (DKD) is the main cause of chronic kidney disease (CKD), which is characterized by mesangial expansion, glomerulosclerosis, tubular atrophy, and interstitial fibrosis. The hallmark of the pathogenesis of DKD is an increased extracellular matrix (ECM) accumulation causing thickening of the glomerular and tubular basement membranes, mesangial expansion, sclerosis, and tubulointerstitial fibrosis. The matrix metalloproteases (MMPs) family are composed of zinc-dependent enzymes involved in the degradation and hydrolysis of ECM components. Several MMPs are expressed in the kidney; nephron compartments, vasculature and connective tissue. Given their important role in DKD, several studies have been performed in patients with DKD proposing that the measurement of their activity in serum or in urine may become in the future markers of early DKD. Studies from diabetic nephropathy experimental models suggest that a balance between MMPs levels and their inhibitors is needed to maintain renal homeostasis. This review focuses in the importance of the MMPs within the kidney and their modifications at the circulation, kidney and urine in patients with DKD. We also cover the most important studies performed in experimental models of diabetes in terms of MMPs levels, renal expression and its down-regulation effect.

6 April 2017 in Journal of Magnetic Resonance Imaging
Verified
Journal Article
Closed access
PDF file
JMJosé María Mora-Gutiérrez
José María Mora-Gutiérrez
NGNuria Garcia-Fernandez
Nuria Garcia-Fernandez
MRM. Fernanda Slon Roblero
M. Fernanda Slon Roblero
JPJosé A Páramo
José A Páramo
JEJavier Escalada
Javier Escalada
MFMaría. A. Fernández-Seara
María. A. Fernández-Seara

Verified
Journal Article
Open access
PDF file
JMJosé María Mora-Gutiérrez
José María Mora-Gutiérrez
MFMaría. A. Fernández-Seara
María. A. Fernández-Seara
RERebeca Echeverria-Chasco
Rebeca Echeverria-Chasco
NGNuria Garcia-Fernandez
Nuria Garcia-Fernandez
Renal magnetic resonance imaging (MRI) techniques are currently in vogue, as they provide in vivo information on renal volume, function, metabolism, perfusion, oxygenation, and microstructural alterations, without the need for exogenous contrast media. New imaging biomarkers can be identified using these tools, which represent a major advance in the understanding and study of the different pathologies affecting the kidney. Diabetic kidney disease (DKD) is one of the most important diseases worldwide due to its high prevalence and impact on public health. However, its multifactorial etiology poses a challenge for both basic and clinical research. Therefore, the use of novel renal MRI techniques is an attractive step forward in the comprehension of DKD, both in its pathogenesis and in its detection and surveillance in the clinical practice. This review article outlines the most promising MRI techniques in the study of DKD, with the purpose of stimulating their clinical translation as possible tools for the diagnosis, follow-up, and monitoring of the clinical impacts of new DKD treatments.

1 May 2017 in Revista Española de Geriatría y Gerontología
Verified
Journal Article
Closed access
JMJosé María Mora-Gutiérrez
José María Mora-Gutiérrez
MRMaría Fernanda Slon Roblero
María Fernanda Slon Roblero
IBItziar Castaño Bilbao
Itziar Castaño Bilbao
DBDiana Izquierdo Bautista
Diana Izquierdo Bautista
JCJesús Arteaga Coloma
Jesús Arteaga Coloma
NMNicolas Martinez-Velilla
Nicolas Martinez-Velilla

19 January 2024 in Journal of Magnetic Resonance Imaging
Verified
Journal Article
Open access
RERebeca Echeverria-Chasco
Rebeca Echeverria-Chasco
PPaloma Martín
Paloma Martín
VAVeronica Aramendía‐Vidaurreta
Veronica Aramendía‐Vidaurreta
LGLeyre Garcia‐Ruiz
Leyre Garcia‐Ruiz
JMJosé María Mora-Gutiérrez
José María Mora-Gutiérrez
MFMaría. A. Fernández-Seara
María. A. Fernández-Seara
Background: Multiparametric MRI provides assessment of functional and structural parameters in kidney allografts. It offers a non‐invasive alternative to the current reference standard of kidney biopsy.Purpose: To evaluate the diagnostic and prognostic utility of MRI parameters in the assessment of allograft function in the first 3‐months post‐transplantation.Study Type: Prospective.Subjects: 32 transplant recipients (54 ± 17 years, 20 females), divided into two groups according to estimated glomerular filtration rate (eGFR) at 3‐months post‐transplantation: inferior graft function (IGF; eGFR<45 mL/min/1.73 m2, n = 10) and superior graft function (SGF; eGFR ≥ 45 mL/min/1.73 m2, n = 22). Further categorization was based on the need for hemodialysis (C1) and decrease in s‐creatinine (C2) at 1‐week post‐transplantation: delayed‐graft‐function (DGF: n = 4 C1, n = 10 C2) and early graft‐function (EGF: n = 28 C1, n = 22 C2).Field Strength/Sequence: 3‐T, pseudo‐continuous arterial spin labeling, T1‐mapping, and diffusion‐weighted imaging.Assessment: Multiparametric MRI was evaluated at 1‐week in all patients and 3‐months after transplantation in 28 patients. Renal blood flow (RBF), diffusion coefficients (ADC, ΔADC, D, D, D*, flowing fraction f), T1 and T1 were calculated in cortex and medulla. The diagnostic and prognostic value of these parameters, obtained at 3‐months and 1‐week post‐transplantation, respectively, was evaluated in the cortex to discriminate between DGF and EGF, and between SGF and IGF.Statistical Tests: Logistic regression, receiver‐operating‐characteristics, area‐under‐the‐curve (AUC), confidence intervals (CIs), analysis‐of‐variance, t‐test, Wilcoxon‐Mann–Whitney test, Fisher's exact test, Pearson's correlation. P‐value<0.05 was considered significant.Results: DGF patients exhibited significantly lower cortical RBF and f and higher D*. The diagnostic value of MRI for detecting DGF was excellent (AUC = 100%). Significant differences between patients with IGF and SGF were found in RBF, ∆T1, and ∆D. Multiparametric MRI showed higher diagnostic (AUC = 95.32%; CI: 88%–100%) and prognostic (AUC = 97.47%, CI: 92%–100%) values for detecting IGF than eGFR (AUC = 89.50%, CI: 79%–100%).Data Conclusion: Multiparametric MRI may show high diagnostic and prognostic value in transplanted patients, yielding better results compared to eGFR measurements.Level of Evidence: 2Technical Efficacy: Stage 1

24 August 2022 in Nutrients
Verified
Journal Article
Open access
PDF file
DADaria Abasheva
Daria Abasheva
MDMarta M. Dolcet-Negre
Marta M. Dolcet-Negre
MFMaría. A. Fernández-Seara
María. A. Fernández-Seara
JMJosé María Mora-Gutiérrez
José María Mora-Gutiérrez
JOJosune Orbe
Josune Orbe
NGNuria Garcia-Fernandez
Nuria Garcia-Fernandez
Background: Matrix metalloproteinase-10 (MMP-10) levels increase progressively starting from early diabetic kidney disease (DKD) stages. Vitamin D3 (vitD3) deficit is associated with a higher risk of diabetic microangiopathy. Reduced MMP-10 expression has been observed after exposure to vitD3. Aim: to assess how vitD3 status is related to MMP-10 levels in patients with Type 2 diabetes (T2D). Methods: 256 patients with T2D were included in this cross-sectional study. Demographic, clinical and serum MMP-10 and 25-hydroxyvitamin D3 (25(OH)D3) levels were collected from each patient. The association between MMP-10 and (25(OH)D3) levels was assessed using a correlation analysis and fitting a multivariate linear regression model. Results: Serum MMP-10 levels were inversely correlated with circulating 25(OH)D3 (rho = −0.25; p < 0.001). In the subgroup analysis this correlation was significant in patients with DKD (rho = −0.28; p = 0.001) and in subjects with vitD3 deficit (rho = −0.24; p = 0.005). In the regression model adjusted for kidney function, body adiposity, smoking and vitD supplementation MMP-10 levels were 68.7 pg/mL lower in patients with 25(OH)D3 > 20 ng/mL, with respect to ≤20 ng/mL (p = 0.006). Conclusions: vitD3 repletion status is an independent predictor of MMP-10 levels in T2D patients. Perhaps, high 25(OH)D3 values should be targeted in these patients in order to prevent vascular complications.